Breaking News Instant updates and real-time market news.

TROV

Trovagene

$1.02

-0.055 (-5.12%)

07:55
10/24/18
10/24
07:55
10/24/18
07:55

Trovagene to host conference call

Management provides an update on Onvansertib clinical program including data from the ongoing Phase 1b Acute Myeloid Leukemia (AML) and metastatic Castration-Resistant Prostate Cancer (mCRPC) trials on a conference call to be held on October 24 at 8:30 am. Webcast Link

  • 24

    Oct

TROV Trovagene
$1.02

-0.055 (-5.12%)

06/18/18
06/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Francesca's (FRAN) upgraded to Buy from Neutral at B. Riley FBR with analyst Susan Anderson saying she has increased confidence in the company's turnaround following meetings with management. 2. Chevron (CVX) upgraded to Outperform from Market Perform at Raymond James with analyst Pavel Molchanov saying Chevron offers relatively more leverage than most peers to higher oil prices, which should reach cyclical highs over the next 6 to 12 months, while low WTI exposure maximizes earnings and free cash flow generation. 3. Trovagene (TROV) upgraded to Buy from Hold at Maxim with analyst Jason McCarthy citing the positive news from the company's lead drug candidate PCM-075 as well as its completion of a capital raise. 4. RBS (RBS) upgraded to Buy from Hold at Investec. 5. Teva (TEVA) upgraded to Market Perform from Underperform at Wells Fargo with analyst David Maris citing a "positive meeting" with Teva's CEO Kundefinedre Schultz and CFO Mike McClellan in Israel. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/18/18
MAXM
06/18/18
UPGRADE
Target $3
MAXM
Buy
Trovagene upgraded to Buy at Maxim on positive PCM-075 news
As reported earlier Maxim analyst Jason McCarthy upgraded Trovagene to Buy from Hold with a price target of $3, citing the positive news from the company's lead drug candidate PCM-075 as well as its completion of a capital raise. The analyst notes that Trovagene's balance sheet now gives it a run rate into the second half of 2019 while the PCM-075 studies progress toward their next set of catalysts. Given the suspension of the financing overhang, McCarthy says the company's potential justifies a more constructive stance.
06/15/18
MAXM
06/15/18
UPGRADE
MAXM
Buy
Trovagene upgraded to Buy from Hold at Maxim
12/21/17
HCWC
12/21/17
INITIATION
Target $1
HCWC
Buy
Trovagene initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started Trovagene with a Buy rating and $1 price target. The analyst believes the company's PCM-075 is differentiated from other ATP-competitive PLK1 inhibitors.

TODAY'S FREE FLY STORIES

AWK

American Water

$97.50

-0.22 (-0.23%)

05:52
12/11/18
12/11
05:52
12/11/18
05:52
Earnings
American Water sees FY19 EPS $3.54-$3.64, consensus $3.55 »

American Water is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

DDAIF

Daimler AG

$0.00

(0.00%)

05:52
12/11/18
12/11
05:52
12/11/18
05:52
Hot Stocks
Daimler to buy battery cells worth more than EUR20B by 2030 »

Daimler is taking the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWK

American Water

$97.50

-0.22 (-0.23%)

05:50
12/11/18
12/11
05:50
12/11/18
05:50
Earnings
American Water backs FY18 adj. EPS view $3.27-$3.32, consensus $3.30 »

American Water affirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

TLRA

Telaria

$2.89

0.12 (4.33%)

05:49
12/11/18
12/11
05:49
12/11/18
05:49
Conference/Events
Telaria management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 17

    Dec

  • 18

    Dec

TILE

Interface

$14.96

-0.17 (-1.12%)

05:48
12/11/18
12/11
05:48
12/11/18
05:48
Conference/Events
Interface management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

WPP

WPP

$51.13

-0.98 (-1.88%)

05:47
12/11/18
12/11
05:47
12/11/18
05:47
Periodicals
WPP to cut 3,500 jobs worldwide as part of restructuring efforts, FT reports »

WPP will cut 3,500 jobs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

TCBK

TriCo Bancshares

$36.22

-0.1 (-0.28%)

05:47
12/11/18
12/11
05:47
12/11/18
05:47
Conference/Events
TriCo Bancshares management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 13

    Dec

  • 14

    Dec

SFIX

Stitch Fix

$25.92

-0.42 (-1.59%)

05:47
12/11/18
12/11
05:47
12/11/18
05:47
Downgrade
Stitch Fix rating change  »

Stitch Fix downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYX

Systemax

$30.46

4.37 (16.75%)

05:45
12/11/18
12/11
05:45
12/11/18
05:45
Conference/Events
Systemax management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

WPP

WPP

$51.13

-0.98 (-1.88%)

05:45
12/11/18
12/11
05:45
12/11/18
05:45
Hot Stocks
WPP sees medium-term organic growth in line with peers »

The company will incur…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

05:45
12/11/18
12/11
05:45
12/11/18
05:45
General news
NFIB Small Business Optimism Index level to be reported at 06:00 »

November NFIB Small…

WPP

WPP

$51.13

-0.98 (-1.88%)

05:44
12/11/18
12/11
05:44
12/11/18
05:44
Hot Stocks
WPP to incur cash costs for restructuring of GBP300M over three years »

WPP announces the results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

FB

Facebook

$141.87

4.45 (3.24%)

05:40
12/11/18
12/11
05:40
12/11/18
05:40
Periodicals
Vishal Shah named head of product for all of Instagram, Recode reports »

Vishal Shah, a product…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,040.02

3.5 (0.34%)

, GOOGL

Alphabet Class A

$1,052.80

5.81 (0.55%)

05:39
12/11/18
12/11
05:39
12/11/18
05:39
Hot Stocks
YouTube bans Proud Boys founder Gavin McInnes »

The YouTube account of…

GOOG

Alphabet

$1,040.02

3.5 (0.34%)

GOOGL

Alphabet Class A

$1,052.80

5.81 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 03

    Mar

CWBR

CohBar

$3.64

0.17 (4.90%)

05:37
12/11/18
12/11
05:37
12/11/18
05:37
Conference/Events
CohBar to host business news update conference call »

Conference call to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

WMT

Walmart

$93.92

0.71 (0.76%)

05:36
12/11/18
12/11
05:36
12/11/18
05:36
Hot Stocks
Walmart, Rakuten open first Walmart ecommerce store in Japan »

Rakuten, Inc. and Walmart…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNFT

Benefitfocus

$50.82

(0.00%)

05:30
12/11/18
12/11
05:30
12/11/18
05:30
Recommendations
Benefitfocus analyst commentary  »

Benefitfocus price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

VRNT

Verint

$44.86

-0.23 (-0.51%)

05:25
12/11/18
12/11
05:25
12/11/18
05:25
Recommendations
Verint analyst commentary  »

Verint price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

NCSM

NCS Multistage

$6.84

-0.37 (-5.13%)

05:22
12/11/18
12/11
05:22
12/11/18
05:22
Downgrade
NCS Multistage rating change  »

NCS Multistage downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLCJY

SLC Agricola

$0.00

(0.00%)

05:20
12/11/18
12/11
05:20
12/11/18
05:20
Upgrade
SLC Agricola rating change  »

SLC Agricola upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$44.41

0.49 (1.12%)

05:18
12/11/18
12/11
05:18
12/11/18
05:18
Downgrade
Pfizer rating change  »

Pfizer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 18

    Dec

IKTSY

Intertek

$0.00

(0.00%)

05:13
12/11/18
12/11
05:13
12/11/18
05:13
Upgrade
Intertek rating change  »

Intertek upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEX

Wex

$152.58

-0.875 (-0.57%)

05:07
12/11/18
12/11
05:07
12/11/18
05:07
Downgrade
Wex rating change  »

Wex downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

FLT

FleetCor

$186.15

-0.78 (-0.42%)

05:06
12/11/18
12/11
05:06
12/11/18
05:06
Downgrade
FleetCor rating change  »

FleetCor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

FIS

FIS

$105.72

1.07 (1.02%)

05:05
12/11/18
12/11
05:05
12/11/18
05:05
Upgrade
FIS rating change  »

FIS upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.